189 related articles for article (PubMed ID: 19667403)
1. Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior.
Forconi F; Sozzi E; Cencini E; Zaja F; Intermesoli T; Stelitano C; Rigacci L; Gherlinzoni F; Cantaffa R; Baraldi A; Gallamini A; Zaccaria A; Pulsoni A; Gobbi M; Tassi M; Raspadori D; Leoncini L; Rinaldi A; Sabattini E; Bertoni F; Pileri SA; Lauria F
Blood; 2009 Nov; 114(21):4696-702. PubMed ID: 19667403
[TBL] [Abstract][Full Text] [Related]
2. VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.
Arons E; Suntum T; Stetler-Stevenson M; Kreitman RJ
Blood; 2009 Nov; 114(21):4687-95. PubMed ID: 19745070
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and molecular characteristics and prognosis of classical hairy cell leukemia and hairy cell leukemia variant].
Wei C; Jin XX; Cai H; Wang X; Zhuang JL; Zhou DB
Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):416-421. PubMed ID: 37032137
[No Abstract] [Full Text] [Related]
4. Molecular variant of hairy cell leukemia with poor prognosis.
Arons E; Kreitman RJ
Leuk Lymphoma; 2011 Jun; 52 Suppl 2(Suppl 2):99-102. PubMed ID: 21599610
[TBL] [Abstract][Full Text] [Related]
5. Hairy cell leukaemia-variant: Disease features and treatment.
Matutes E; Martínez-Trillos A; Campo E
Best Pract Res Clin Haematol; 2015 Dec; 28(4):253-63. PubMed ID: 26614904
[TBL] [Abstract][Full Text] [Related]
6. Molecular insight into the biology and clinical course of hairy cell leukemia utilizing immunoglobulin gene analysis.
Forconi F; Cencini E; Sicuranza A; Sozzi E; Lauria F
Leuk Lymphoma; 2011 Jan; 52(1):15-23. PubMed ID: 21133731
[TBL] [Abstract][Full Text] [Related]
7. Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.
Panovská A; Žák P; Jurková T; Arpáš T; Brychtová Y; Vašíková A; Hrabčáková V; Prchlíková A; Filipová M; Doubek M
Hematol Oncol; 2024 May; 42(3):e3280. PubMed ID: 38741354
[TBL] [Abstract][Full Text] [Related]
8. Insight into the behavior of hairy cell leukemia by immunogenetic analysis.
Forconi F; Cencini E; Sozzi E; Sicuranza A; Raspadori D; Lauria F
Leuk Lymphoma; 2011 Jun; 52 Suppl 2():103-7. PubMed ID: 21504291
[TBL] [Abstract][Full Text] [Related]
9. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland.
Robak T; Błasińska-Morawiec M; Błoński J; Hellmann A; Hałaburda K; Konopka L; Kotlarek-Haus S; Potoczek S; Hansz J; Dmoszyńska A; Urasiński I; Zdziarska B; Dwilewicz-Trojaczek J; Hołowiecki J; Skotnicki AB
Eur J Haematol; 1999 Jan; 62(1):49-56. PubMed ID: 9918312
[TBL] [Abstract][Full Text] [Related]
10. Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial.
Chihara D; Kantarjian H; O'Brien S; Jorgensen J; Pierce S; Faderl S; Ferrajoli A; Poku R; Jain P; Thompson P; Brandt M; Luthra R; Burger J; Keating M; Ravandi F
Br J Haematol; 2016 Sep; 174(5):760-6. PubMed ID: 27301277
[TBL] [Abstract][Full Text] [Related]
11. Cladribine in hairy cell leukemia.
Belani R; Saven A
Hematol Oncol Clin North Am; 2006 Oct; 20(5):1109-23. PubMed ID: 16990111
[TBL] [Abstract][Full Text] [Related]
12. Complete molecular remission induced by concomitant cladribine--rituximab treatment in a case of multi-resistant hairy cell leukemia.
Forconi F; Toraldo F; Sozzi E; Amato T; Raspadori D; Lauria F
Leuk Lymphoma; 2007 Dec; 48(12):2441-3. PubMed ID: 18067021
[No Abstract] [Full Text] [Related]
13. Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemia.
Le Bris Y; Struski S; Guièze R; Rouvellat C; Prade N; Troussard X; Tournilhac O; Béné MC; Delabesse E; Ysebaert L
Hematol Oncol; 2017 Dec; 35(4):664-670. PubMed ID: 27678008
[TBL] [Abstract][Full Text] [Related]
14. Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation.
Xi L; Arons E; Navarro W; Calvo KR; Stetler-Stevenson M; Raffeld M; Kreitman RJ
Blood; 2012 Apr; 119(14):3330-2. PubMed ID: 22210875
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series.
Rosenberg JD; Burian C; Waalen J; Saven A
Blood; 2014 Jan; 123(2):177-83. PubMed ID: 24192579
[TBL] [Abstract][Full Text] [Related]
16. Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trial.
Bühler A; Wendtner CM; Kipps TJ; Rassenti L; Fraser GA; Michallet AS; Hillmen P; Dürig J; Gregory SA; Kalaycio M; Aurran-Schleinitz T; Trentin L; Gribben JG; Chanan-Khan A; Purse B; Zhang J; De Bedout S; Mei J; Hallek M; Stilgenbauer S
Blood Cancer J; 2016 Mar; 6(3):e404. PubMed ID: 26967821
[TBL] [Abstract][Full Text] [Related]
17. Multicenter retrospective analysis regarding the clinical manifestations and treatment results in patients with hairy cell leukemia: twenty-four year Turkish experience in cladribine therapy.
Hacioglu S; Bilen Y; Eser A; Sivgin S; Gurkan E; Yildirim R; Aydogdu I; Dogu MH; Yilmaz M; Kayikci O; Tombak A; Kuku I; Celebi H; Akay MO; Esen R; Korkmaz S; Keskin A
Hematol Oncol; 2015 Dec; 33(4):192-8. PubMed ID: 25393847
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General Population.
Madanat YF; Rybicki L; Radivoyevitch T; Jagadeesh D; Dean R; Pohlman B; Kalaycio M; Sekeres MA; Smith MR; Hill BT
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):857-862. PubMed ID: 28778620
[TBL] [Abstract][Full Text] [Related]
19. Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia.
Thompson PA; Tam CS; O'Brien SM; Wierda WG; Stingo F; Plunkett W; Smith SC; Kantarjian HM; Freireich EJ; Keating MJ
Blood; 2016 Jan; 127(3):303-9. PubMed ID: 26492934
[TBL] [Abstract][Full Text] [Related]
20. Treatment of hairy cell leukemia-variant with cladribine.
Tetreault SA; Robbins BA; Saven A
Leuk Lymphoma; 1999 Oct; 35(3-4):347-54. PubMed ID: 10706459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
